A population association study of four candidate genes (hexokinase II, glucagon-like peptide-1 receptor, fatty acid binding protein-2, and apolipoprotein C-II) with Type 2 diabetes and impaired glucose tolerance in Japanese subjects

Diabetic Medicine

Volumn 13, Issue 10, 1996, Pages 902-907

  Yagi, T ^a   Nishi, S ^a,b   Hinata, S I ^c   Murakami, M ^d   Yoshimi, T ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c Hamaoka Municipal Hospital   (Japan)

^d University of Tokyo   (Japan)

Author keywords

Apolipoprotein C II; Fatty acid binding protein 2; Glucagon like peptide 1 receptor; Hexokinase II

Indexed keywords

GLUCOSE; HEXOKINASE; LIPID;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; JAPAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS;

APOLIPOPROTEIN C-II; APOLIPOPROTEINS C; CARRIER PROTEINS; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DNA PRIMERS; FATTY ACID-BINDING PROTEINS; FATTY ACIDS; FEMALE; GENOTYPE; GLUCOSE INTOLERANCE; HEXOKINASE; HUMANS; JAPAN; MALE; MIDDLE AGED; MYELIN P2 PROTEIN; NEOPLASM PROTEINS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RECEPTORS, GLUCAGON; REFERENCE VALUES; REPETITIVE SEQUENCES, NUCLEIC ACID; TUMOR SUPPRESSOR PROTEINS;

EID: 0029848580     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9136(199610)13:10<902::AID-DIA242>3.0.CO;2-O     Document Type: Article

References (29)

1. Vionnet N, Stoffel M, Takeda J, Yasuda K, Bell GI, Zouali H, et al. Nonsense mutation in the glucokinase gene causes early-onset non-insulin dependent diabetes mellitus. Nature 1992; 356: 721-722.
2. Stoffel M, Froguel Ph, Takeda J, Zouali H, Vionnet N, Nishi S, et al. Human glucokinase gene: isolation and characterization and identification of two missense mutation linked to early-onset non-insulin-dependent (type 2) diabetes mellitus. Proc Acad Sd USA 1992; 89: 7698-7702.
3. Stoffel M, Patel P, Lo YMD, Hattersley AT, Lucassen AM, Page R, et al. Characterization of a missense glucokinase mutation in maturity-onset diabetes of the young and mutation screening in late-onset diabetes. Nature Genetics 1992; 2: 153-156.
4. Leu(UUR) gene in a large pedigree with maternally transmitted type II diabetes mellitus and deafness. Nature Genetics 1992; 1: 368-371.
5. Leu(UUR) gene. FEBS Lett 1993; 321: 194-196.
6. Reardon W, Ross RJM, Sweeney MG, Luxon LM, Pembrey ME, Harding AE, et al. Diabetes mellitus associated with a pathogenic point mutation in mitochondrial DNA. Lancet 1992; 340: 1376-1379.
7. Oka Y, Katagiri H, Yazaki Y, Murase T, Kobayashi T. Mitochondrial gene mutation in islet-cell-antibody-positive patients who were initially non-insulin-dependent diabetics. Lancet 1993; 342: 527-528.
8. Nishi S, Hinata S, Matsukage T, Takeda J, Ichiyama A, Bell GI, et al. Mutations in the glucokinase gene are not a major cause of late-onset Type 2 diabetes mellitus in Japanese subjects. Diabetic Med 1994; 11: 193-197.
9. Printz RL, Koch S, Potter LR, O'Doherty RM, Tiesinga JJ, Moritz S, et al. Hexokinase II mRNA and gene structure, regulation by insulin, and evolution, J Biol Chem 1993; 268: 5209-5219.
10. Braithwaite SS, Palazuk B, Colca JR, Edwards CW III, Hofmann C. Reduced expression of hexokinase II in insulin-resistant diabetes. Diabetes 1995; 44: 43-48.
11. 31P Nuclear magnetic resonance measurements of muscle glucose-6-phosphate: evidence for reduced insulin-dependent muscle glucose transport of phosphorylation in non-insulin-dependent diabetes mellitus. J Clin Invest 1992; 89: 1069-1075.
12. Randle PJ, Garland PB, Hales CN, Newsholme EA. The glucose fatty-acid cycle: its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1963; 1: 785-789.
13. Ferranninni E, Barrett EJ, Bevilacqua S, DeFronzo RA. Effect of fatty acids on glucose production and utilization in man. J Clin Invest 1983; 72: 1737-1747.
14. Glatz JFC, van Breda E, Keizer HA, de Jong YF, Lakey JRT, Rajotte RV, et al. Rat heart fatty acid-binding protein content is increased in experimental diabetes. Biochem Biophys Res Commun 1994; 199: 639-646.
15. Orskov C, Glucagon-like peptide-1, a new hormone of the entero-insular axis. Diabetologia 1992; 35: 701-711.
16. Thorens B, Porret A, Buhler L, Deng S, Morel P, Widmann C. Cloning and functional expression of the human islet GLP-1 receptor. Diabetes 1993; 42: 1678-1682.
17. WHO Expert Committee on Diabetes Mellitus. Diabetes Mellitus Second Report. WHO Technical Report Series 646. Geneva: WHO, 1980.
18. Lehto M, Xiang K, Stoffel M, Epinosa III R, Groop LC, Le Beau MM, et al. Human hexokinase II: localization of the polymorphic gene to chromosome 2. Diabetologia 1993; 36: 1299-1302.
19. Vaxillaire M, Vionnet N, Vigouroux C, Sun F, Esponosa III R, Lebeau MM, et al. Search for a third susceptibility gene for maturity-onset diabetes of the young: studies with eleven candidate genes. Diabetes 1994; 43: 389-395.
20. Saad MF, Knowler WC, Pettitt DJ, Nelson RG, Charles MA, Bennett PH. A two-step model for development of non-insulin-dependent diabetes. Am J Med 1991; 90: 229-235.
21. Lillioja S, Mott DM, Zawadzki JK, Young AA, Abbott WGH, Knowler WC, et al. In vivo insulin action is familial characteristic in nondiabetic Pima Indians. Diabetes 1987; 36: 1329-1335.
22. Laakso M, Malkki M, Deeb SS. Amino acid substitutions in hexokinase II among patients with NIDDM. Diabetes 1995; 44: 330-334.
23. 142→His substitution. Diabetes 1995; 44: 340-346.
24. Echwald SM, Bjφrbak C, Hansen T, Clausen JO, Vestergaard H, Zierath JR, et al. Identification of four amino acid substitutions in hexokinase II and studies of relationships to NIDDM, glucose effectiveness, and insulin sensitivity. Diabetes 1995; 44: 347-353.
25. Stoffel M, Espinosa III R, Le Beau MM, Bell GI. Human glucagon-like peptide-1 receptor gene: localization to chromosome band 6p21 by fluorescence in situ hybridization and linkage of a highly polymorphic simple tandem repeat DNA polymorphism to other markers on chromosome 6. Diabetes 1993; 42: 1215-1218.
26. Tanizawa Y, Riggs AC, Elbein SC, Whelan A, Donis-Keller H, Permutt MA. Human glucagon-like peptide-1 receptor gene in NIDDM: identification and use of simple sequence repeat polymorphism in genetic analysis. Diabetes 1994; 43: 752-757.
27. Prochazka M, Lillioja S, Tait JF, Knowler WC, Mott DM, Spraul M, et al. Linkage of chromosomal markers on 4q with a putative gene determining maximal insulin action in Pima Indians. Diabetes 1993; 42: 514-519.
28. Humphreys P, McCarthy M, Tuomilhto J, Tuomilehto-Wolf E, Stratton I, Morgan R, et al. Chromosome 4q locus associated with insulin resistance in Pima Indians: studies in three European NIDDM populations. Diabetes 1994; 43: 800-804.
29. Arslanian SA, Kalha SC. Correlations between fatty acid and glucose metabolism: potential explanation of insulin resistance of puberty. Diabetes 1994; 43: 908-914.